“The caliber of talks was unrelenting…nothing short of stellar!”

– 2019 AGBT Precision Health Attendee

On June 15th, California lifted most remaining crowd-capacity limits and physical distancing requirements. Read more about the California Guidelines, and the Loews safety protocols. To ensure a spot, REGISTER EARLY.

Our commitment

Now, more than ever, it’s important for those of us with a stake in the healthcare community to come together to share our latest research and discoveries, and identify opportunities for innovation and strategic deployment of life-sustaining products and services. By joining forces as a multidisciplinary and cross-industry community dedicated to delivering solutions to growing challenges, we can face the future with renewed optimism for creating a better world.


Joshua C. Denny

Josh Denny is the Chief Executive Officer of the National Institutes of Health’s All of Us Research Program. He has been involved in All of Us from its inception, first as a member of the Advisory Committee to the (NIH) Director Precision Medicine Initiative Working Group, which developed the program’s initial scientific blueprint. He led […]


Mary De Silva

Mary De Silva leads the Population Health team which directs Wellcome’s funding of population health research in the UK and in low- and middle-income countries. Our portfolio spans aetiological research to understand the individual and wider determinants of health, and translational science to develop and test effective and scalable interventions to prevent and treat ill health, ensure health systems are robust, and that evidence is translated into policy and practice. Current strategic areas of interest include Wellcome’s Longitudinal […]


Sekar Kathiresan

Sekar Kathiresan is co-founder and chief executive officer of Verve Therapeutics and serves on the company’s board of directors. He is a preventive cardiologist who has made groundbreaking discoveries of cardioprotective genetic mutations, which confer resistance to cardiovascular disease. Prior to joining Verve, he served as director of the Massachusetts General Hospital (MGH) Center for […]


Joyce Tung

Joyce Tung is Vice President of Research at 23andMe, and manages the 23andMe research team, which is responsible for new research methods and tools development, genetics discovery for therapeutics target identification and validation, academic and industry research collaborations, and the ethical conduct of 23andMe’s consumer-based research program. Before joining 23andMe in 2007. Joyce was a […]


The Genome Partnership convenes the world’s most revered genome science and technology conferences, bringing together top global researchers, leaders, and innovators in human health and agriculture. The Genome Partnership has been proudly organizing The Advances in Genome Biology and Technology (AGBT) meetings since 1999. The Genome Partnership, based in St. Louis, is a not-for-profit organization and its mission is to advance research, promote education, and expand commerce in genome science and technology. For more information visit


This was the best conference I have ever attended. The talks were stellar and I really enjoyed the small size relative to the larger meetings I typically attend…it was more personalized and meaningful.

2019 AGBT Precision Health Attendee

The caliber of talks was unrelenting…nothing short of stellar!

2019 AGBT Precision Health Attendee

I enjoyed learning how the rest of the field is thinking about genomic testing (i.e. combining WGS and RNAseq) The scientific content was excellent and I made a lot of new connections. 

2019 AGBT Precision Health Attendee

Very distinguished serIes of speakers from diverse clinical fields and perspectives with common genomic thread. Best collection of talks I’ve seen at a conference lately.

2018 AGBT Precision Health Attendee